Drug Type siRNA |
Synonyms TGN-208 |
Target |
Action inhibitors |
Mechanism NPR1 gene inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Immune System Diseases | Discovery | United States | - | |
| Neoplasms | Discovery | United States | - |





